Helius Medical Technologies, Inc.
HSDT
$4.18
-$0.24-5.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.00K | 141.00K | 40.00K | 171.00K | 124.00K |
| Total Other Revenue | 11.00K | 11.00K | 11.00K | 11.00K | 11.00K |
| Total Revenue | 49.00K | 152.00K | 51.00K | 182.00K | 135.00K |
| Cost of Revenue | 121.00K | 154.00K | 187.00K | 118.00K | 123.00K |
| Gross Profit | -72.00K | -2.00K | -136.00K | 64.00K | 12.00K |
| SG&A Expenses | 2.99M | 2.18M | 2.85M | 2.46M | 2.63M |
| Depreciation & Amortization | -- | 3.00K | 7.00K | 7.00K | 7.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.06M | 3.26M | 4.12M | 3.45M | 3.55M |
| Operating Income | -4.01M | -3.11M | -4.07M | -3.27M | -3.42M |
| Income Before Tax | -3.84M | -3.93M | -3.69M | -1.61M | -2.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.84M | -3.93M | -3.69M | -1.61M | -2.52M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.84M | -3.93M | -3.69M | -1.61M | -2.52M |
| EBIT | -4.01M | -3.11M | -4.07M | -3.27M | -3.42M |
| EBITDA | -4.00M | -3.10M | -4.05M | -3.25M | -3.40M |
| EPS Basic | -7.62 | -15.72 | -14.78 | -9.60 | -46.18 |
| Normalized Basic EPS | -4.76 | -9.73 | -9.24 | -6.00 | -28.86 |
| EPS Diluted | -7.65 | -15.72 | -14.85 | -9.60 | -46.20 |
| Normalized Diluted EPS | -4.76 | -9.73 | -9.24 | -6.00 | -28.86 |
| Average Basic Shares Outstanding | 503.80K | 249.90K | 249.40K | 167.90K | 54.50K |
| Average Diluted Shares Outstanding | 503.80K | 249.90K | 249.40K | 167.90K | 54.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |